Free press releases distribution network?

Agency / Source: Visiongain

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



World Biomarkers Market will Reach $15.29 Billion in 2012 New Visiongain Report Predicts - A new report by visiongain predicts that the global market for biomarkers will be worth $15.29 billion in 2012 - Visiongain.com
World Biomarkers Market will Reach $15.29 Billion in 2012 New Visiongain Report Predicts

 

PRZOOM - /newswire/ - London, United Kingdom, 2012/07/24 - A new report by visiongain predicts that the global market for biomarkers will be worth $15.29 billion in 2012 - Visiongain.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Between 2011 and 2016, the world market will grow with a CAGR of 11.0%. Increased use of biomarkers in drug development will drive growth. Those findings appear in Biomarkers: Technological and Commercial Outlook 2012-2022, published in July 2012.

Visiongain forecasts that biomarker diagnostics will be the biggest sector of the market in 2022, overtaking biomarker development and technologies, in terms of revenue, in 2017. In 2011, biomarker diagnostics achieved revenue of $5.55bn. Increased demand for companion diagnostics and non-invasive tests will drive growth in this sector. Leading market players include pharmaceutical companies co-developing drugs and diagnostics - such as Roche Diagnostics - and leading diagnostic developers, including Genomic Health and Myriad Genetics.

Richard Lang, a pharmaceutical industry analyst in visiongain, said: “Doctors, patients and healthcare payers are demanding new tools for early and accurate diagnosis of disease. Biomarkers represent a strong opportunity for the development of non-invasive diagnostic and prognostic tests. Identifying the most suitable treatment for a patient will cut healthcare spending and help avoid potential adverse events. Other drivers for growth in the biomarkers market in coming years will be the increased validation of biomarkers. Many markers were discovered in the past decade but relatively few have been commercialised.”

This study forecasts the future of three key disciplines in the biomarkers market: genomics, proteomics and bioinformatics. In 2011, genomics accounted for the largest share of biomarker research, driven by initiatives such as The Cancer Genome Atlas and the International Cancer Genome Consortium. In the coming 10 years newer disciplines for biomarker discovery, including metabolomics and glycomics, will receive greater attention.

Visiongain’s report also provides revenue forecasts for leading national markets for biomarker diagnostics and technologies. In 2011, the US was the leading market for biomarkers, accounting for over 60% of global revenues in that year. Strong growth is forecast for that national market, driven by the approval of diagnostics and the integration of biomarkers into drug development. Many of the market leading companies are based in the US. Increasing availability of biomarker technologies in China will drive market growth there. In 2016, that national market will be valued at $0.66bn.

Biomarkers: Technological and Commercial Outlook 2012-2022 assesses the market in terms of sector, discipline, therapeutic area and country. The study adds to visiongain’s portfolio of analytical reports covering the pharmaceutical and healthcare technology markets. Visiongain is a business information provider based in London, UK.

For sample pages and further information concerning the visiongain report Biomarkers: Technological and Commercial Outlook 2012-2022 please visit the website.

About Visiongain
Visiongain (visiongain.com) is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Visiongain

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


World Biomarkers Market will Reach $15.29 Billion in 2012 New Visiongain Report Predicts

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Sara Peerun - Visiongain.com 
+44(0)20 7336 6100 sara.peerun[.]visiongainglobal.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Visiongain securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Visiongain / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com

Visit  RightITnow Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today